Osteopore Limited announced changes to its Board of Directors. The company announced that Mark Leong, who joined it's Board as Chairman and Non-Executive Director on 01 August 2021, will be taking on the role of Osteopore's Executive Chairman and Director, effective 28 December 2021. Mr. Leong, a Fellow of the Association of Chartered Certified Accountants (ACCA) and Member of the Singapore Institute of Directors (SID), has more than 22 years of corporate experience in a broad range of functions, including several C suite appointments as well as various executive and non-executive directorship roles in both private and public companies. Based in Singapore and actively engaged with the local team, Mr. Leong brings a strong background in South- East Asian capital markets. The company announced that it has secured the experienced corporate executive Vlado Bosanac as the Non-Executive Senior Independent Director. Mr. Bosanac combines over 30 years' experience in capital markets, deal origination, negotiation, corporate advisory, strategy, project implementation, leveraged and management buy-outs, as well as private and public investment. Over the past 20 years he has focussed on bio-medical, medical device and pharmaceutical development. Over his career, Mr. Bosanac has contributed towards several listing and liquidity events for numerous companies. In June this year, he was appointed to the Board of soon to be listed Singapore based Clean Mining Technologies Limited.